Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)

OBJECTIVES: To investigate whether baseline [(123)I]FP-CIT SPECT and CSF markers can predict cognitive impairment (CI) in PD patients, and provide a profile of those most at risk. METHODS: 262 de novo PD patients from the Parkinson’s Progression Markers Initiative database were stratified into two C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousaf, Tayyabah, Pagano, Gennaro, Niccolini, Flavia, Politis, Marios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469665/
https://www.ncbi.nlm.nih.gov/pubmed/30820739
http://dx.doi.org/10.1007/s00415-019-09250-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469665/
https://www.ncbi.nlm.nih.gov/pubmed/30820739
http://dx.doi.org/10.1007/s00415-019-09250-y

Ejemplares similares